Hollencrest Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52K | Hold |
80
| – | – | ﹤0.01% | 911 |
|
|
2025
Q1 | $2.62K | Hold |
80
| – | – | ﹤0.01% | 914 |
|
|
2024
Q4 | $2.89K | Hold |
80
| – | – | ﹤0.01% | 923 |
|
|
2024
Q3 | $2.49K | Hold |
80
| – | – | ﹤0.01% | 908 |
|
|
2024
Q2 | $2.14K | Hold |
80
| – | – | ﹤0.01% | 888 |
|
|
2024
Q1 | $2.73K | Hold |
80
| – | – | ﹤0.01% | 867 |
|
|
2023
Q4 | $2.32K | Hold |
80
| – | – | ﹤0.01% | 875 |
|
|
2023
Q3 | $2.21K | Hold |
80
| – | – | ﹤0.01% | 907 |
|
|
2023
Q2 | $2.41K | Hold |
80
| – | – | ﹤0.01% | 943 |
|
|
2023
Q1 | $2.9K | Hold |
80
| – | – | ﹤0.01% | 920 |
|
|
2022
Q4 | $2.85K | Buy |
+80
| New | +$2.85K | ﹤0.01% | 900 |
|